Sensus Healthcare, Inc.
(NASDAQ : SRTS)

( )
SRTS After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Medical Specialties
symbolcompany%chnglast%shortavg$volume
TMOThermo Fisher Scientific, Inc. -2.13%290.751.0%$598.50m
BDXBecton, Dickinson & Co. -2.01%237.811.1%$581.31m
MDTMedtronic Plc -0.28%100.700.6%$575.42m
ABTAbbott Laboratories -2.68%77.070.8%$405.79m
DHRDanaher Corp. -1.56%144.750.7%$395.95m
ISRGIntuitive Surgical, Inc. -1.96%533.962.4%$389.78m
BSXBoston Scientific Corp. -1.45%37.371.1%$334.45m
EWEdwards Lifesciences Corp. -4.01%204.431.2%$317.44m
DXCMDexCom, Inc. -1.95%276.008.2%$315.70m
SYKStryker Corp. -2.25%190.471.3%$270.31m
ALGNAlign Technology, Inc. -2.51%218.356.4%$202.83m
BAXBaxter International, Inc. -1.03%83.401.8%$192.04m
ZBHZimmer Biomet Holdings, Inc. -2.85%135.961.7%$182.96m
APTAlpha Pro Tech Ltd. -20.79%20.000.5%$163.00m
IDXXIDEXX Laboratories, Inc. 1.74%254.513.8%$140.35m

Company Profile

Sensus Healthcare, Inc. engages in the design, manufacture, and marketing of proprietary medical devices specializing in the treatment of non-melanoma skin cancers and other skin conditions. Its main product is SRT-100, a photon x-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating basal cell and squamous cell skin cancers and other skin conditions such as keloids. The company was founded by Joseph C. Sardano, Richard Golin, Kalman Fishman and Stephen Cohen on May 7, 2010 and is headquartered in Boca Raton, FL.